About the Company
We do not have any company description for VBI Vaccines Inc/BC at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $VBIV News
VBIV Stock Earnings: VBI Vaccines Beats EPS, Misses Revenue for Q4 2023
VBI Vaccines (NASDAQ:VBIV) just reported results for the fourth quarter of 2023. VBI Vaccines reported earnings per share of -1 cent. This was above the analyst estimate for EPS of -22 cents. The ...
Canadian Investment Regulatory Organization Trading Halt - API
VBI Vaccines Inc. (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced financial ...
Loading the latest forecasts...